Insider filing · GILD
Johanna Mercier
Chief Commercial Officer
profile →
Gilead Sciences, Inc.
GILD · Healthcare · 86 filings in 24 months
ticker →
Johanna Mercier sold $3.1M of Gilead Sciences (GILD)
Executed Aug 15 2025, disclosed Aug 18 2025, 3 days later.
Value, as filed
$3.1M
26,400 sh across 3 lots
Executed
Aug 15 2025
the trade date, as filed
Disclosed
Aug 18 2025
3 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JMJohanna Mercier (Chief Commercial Officer) filed 11 Form 4 reports in the trailing twelve months (0 purchases, 11 sales), most often in Gilead Sciences, Inc. (GILD). The largest single filing was $4.3M of GILD (27,800 sh across 2 lots, as filed), executed Feb 17.
The name
GILDHealthcare · Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Johanna Mercier in GILD
GILDSALE
Gilead Sciences, Inc.
$3.9M28,000 sh across 2 lots
Exec Aug 17
Filed Aug 18 · 6:54 PM ET GILDSALE Gilead Sciences, Inc. $390K
3,000 sh × $129.92
Exec Jul 15
Filed Jul 16 · 4:54 PM ET GILDSALE Gilead Sciences, Inc. $315K
2,550 sh across 2 lots
Exec Jun 15
Filed Jun 16 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. $3.6M
27,300 sh across 3 lots
Exec May 15
Filed May 18 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. $423K
3,000 sh × $140.96
Exec Apr 15
Filed Apr 16 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. $433K
3,000 sh × $144.23
Exec Mar 16
Filed Mar 17 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. $4.3M
27,800 sh across 2 lots
Exec Feb 17
Filed Feb 18 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. $373K
3,000 sh × $124.31
Exec Jan 15
Filed Jan 16 · 5:30 PM ET